Golimumab (Simponi) Market: $3.5B (2024) with 4.1% CAGR
收藏DiMarket2026-07-04 收录
官方服务:
资源简介:
Analyze the Golimumab (Simponi) market, valued at $3.5B in 2024, projecting 4.1% CAGR. Understand key growth drivers, biosimilar impacts, and strategic opportunities.



